Trial Site Detail
Drug: |
Imatinib + Regorafenib |
|||
|---|---|---|---|---|
Trial: |
A Randomised Trial of Imatinib Alternating With Regorafenib Compared to Imatinib Alone for the First Line Treatment of Advanced Gastrointestinal Stromal Tumour (GIST) (ALT GIST) |
|||
| Conditions: | Gastrointestinal Stromal Tumor | |||
Trial Status: |
Active, not recruiting |
|||
National Cancer Center |
Principal Investigator: |
|
|---|---|
Contact: |
ALT GIST Trial Coordinator +6129562500 altgist@ctc.usyd.edu.au |
Activation Status of this Site: |
Active |
Notes about this Site: |
|
National Cancer Center Website: |
Navigating the Map
Use the plus (+) and minus (-) controls to zoom in/out.
Click and drag the map or use the arrows to move (pan) the map.
Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.